glp-1 and vision loss drugs linked to rare loss: JAMA study | Pharmavoice.in posted on the topic Study: Ozempic linked to eye
Description
They're prepared by licensed compounding pharmacies - in Refills' case, PerfectRx LLC, a regulated U.S.-based compounding pharmacy - and dispensed under a licensed provider's prescription
Metabolism 65 (5), 699713
The key consideration is that retatrutide adds glucagon receptor activation that the body has never experienced with either semaglutide or tirzepatide
"Our medical team sees meaningful potential in several peptide therapies, and we are pleased to see the FDA moving to more clearly define what is safe and allowable here," Dudum said
